XML 32 R21.htm IDEA: XBRL DOCUMENT
v3.24.2.u1

Research and Development Costs (Tables) | 6 Months Ended
--- | ---
Jun. 30, 2024
Research and Development [Abstract] |
Schedule of Research and Development Costs | A summary of research and development costs for the three months and six months ended June 30, 2024 and 2023, including costs associated with clinical trials involving the Company’s lead clinical compound LB-100, are summarized below based on the respective geographical regions where such costs have been incurred. Schedule of Research and Development Costs
|  | 2024 |  |  | 2023 |  |  | 2024 |  |  | 2023 |
|  | Three Months Ended June 30, |  |  | Six Months Ended June 30, |
|  | 2024 |  |  | 2023 |  |  | 2024 |  |  | 2023 |
United States |  | $ | 114,345 |  |  | $ | 87,625 |  |  | $ | 148,928 |  |  | $ | 223,531 |
Spain |  |  | 29,244 |  |  |  | 272,564 |  |  |  | 44,478 |  |  |  | 273,539 |
China |  |  | — |  |  |  | 14,090 |  |  |  | 2,282 |  |  |  | 14,090 |
Netherlands |  |  | 67,119 |  |  |  | 53,178 |  |  |  | 134,084 |  |  |  | 105,382 |
Total |  | $ | 210,708 |  |  | $ | 427,457 |  |  | $ | 329,772 |  |  | $ | 616,542 |
Research and development costs |  | $ | 210,708 |  |  | $ | 427,457 |  |  | $ | 329,772 |  |  | $ | 616,542 |

X
- Definition Tabular disclosure of research and developement. + References No definition available. + Details
Name: | LIXT_ResearchDevelopmentTableTextBlock
Namespace Prefix: | LIXT_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_ResearchAndDevelopmentAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration